Skip to content
OpenCapital
Get started

Pyxis Oncology PYXS Q4 2025 Annual earnings

Reported March 23, 2026 · Before market open

Revenue$11.0MBeat by $10.9M
EPS-$0.29Beat by $0.06
Revenue estimate$125.0K
EPS estimate-$0.35

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$33.3K
EPS estimate-$0.34

Versus estimates

Revenue

Q4 2025$11.0MBeat by $10.9M
Q2 2025$2.8MQ4 2024$3.4M

Diluted EPS

Q1 2026-$0.37Miss by $0.02
Q4 2025-$0.29Beat by $0.06
Q3 2025-$0.35Beat by $0.01Q2 2025-$0.30Beat by $0.06Q1 2025-$0.35Miss by $0.06Q4 2024-$0.32Beat by $0.01

Ask the moment Pyxis Oncology reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Pyxis Oncology report Q4 2025 earnings?
Pyxis Oncology (PYXS) reported Q4 2025 earnings on March 23, 2026 before market open.
What were Pyxis Oncology's Q4 2025 revenue and EPS?
Pyxis Oncology reported revenue of $11.0M and eps of $-0.29 for Q4 2025.
Did Pyxis Oncology beat estimates in Q4 2025?
Revenue beat the consensus estimate of $125.0K by $10.9M. EPS beat the consensus estimate of $-0.35 by $0.06.
How did Pyxis Oncology's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 224.5% from $3.4M a year earlier and eps grew 9.4% from $-0.32.
Where can I find Pyxis Oncology's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-118525) and the 10-K periodic report (0001193125-26-118532) directly on SEC EDGAR. The filing index links above go to sec.gov.